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Bone Mineral Density Changes after Orchiectomy using a Scrotal 
Approach in Rats
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Department of Neurosurgery, The Spine and Spinal Cord Institute, Gangnam Severance Hospital, 
Yonsei University College of Medicine, Seoul, Korea
Objective: To investigate a suitable animal model for studies of male osteoporosis. Osteoporosis has a particularly high incidence 
in postmenopausal women, resulting in a substantial amount of research with respect to this disease in women. However, 
research on osteoporosis in men is still lacking.
Methods: Twenty 10-week-old male Sprague Dawley rats were used in this study, including 4 rats used to establish a baseline 
bone mineral density (BMD). The other 16 rats were divided into two groups: a sham surgery group (n=8), which underwent 
a sham operation, and an orchiectomized rat group (OCX) (n=8), which underwent bilateral OCX at 10 weeks of age. Bone mineral 
density was measured in 4 rats from both the sham surgery group and the OCX group 8 weeks after the surgery, while BMD 
in the remainder of the rats was measured 10 weeks post-surgery.
Results: Femoral BMD at 8 weeks post-surgery was found to be significantly lower in the OCX group compared to the sham 
group; a finding that was also similar 10 weeks post-surgery.
Conclusion: 8 weeks after undergoing orchiectomy performed via a scrotal, white rats are a suitable model for studies of male 
osteoporosis.
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INTRODUCTION
Korean society is rapidly aging in comparison to other deve- 
lopd countries. In 2000, Korea became an aging population 
with 7.2% of the total population aged 65 or older. It has 
been estimated that Korea will become an aged society in 2019, 
and a super-aged society in 202617). Hence, it is safe to assume 
that osteoporosis will become the next most important geriatric 
disease, following coronary artery disease (CAD) and diabetes 
mellitus (DM), resulting in rising costs to society for prevention 
and treatment.
Research on osteoporosis has so far been primarily performed 
on postmenopausal women, due to the high incidence of disease 
in this population. However, it is important to acknowledge 
that 14.5% of men who underwent spinal surgery had oste- 
oporosis, which can result in higher reported morbidity and 
mortality if fracture was to occur10). This percentage is one- 
third of that found among women3). For this reason, research 
on male osteoporosis is essential.
Regarding osteoporosis in men, it has been reported that 
the androgen deprivation therapy used in patients with prostate 
cancer is complicated by osteoporosis4) and the high alkaline 
phosphatase levels in these patients14) allows us to deduce that 
bone loss is occurring in these patients. It is also known that 
continued use of androgen deprivation therapy in patients with 
prostate cancer results in a worsening of osteoporosis5). In these 
cases, anti-resorptive drugs, such as bisphosphonate, are used 
in prevention. Consequently, it is very important to understand 
their effect. Many articles have been published regarding the 
effects of anti-resorptive drugs in orchiectomized animal models 
of male osteoporosis1,6,11). However, before the effects of these 
drugs are evaluated in animal models, it is also important to 
validate whether the animal model is already compromised by 
osteoporosis.
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Fig. 1. BMD measurement using NRecon software. BMD was mea-
sured in the femora using micro computed tomography: SkyScan
1173 (Bruker-CT, Kartuizersweg 3B 2550 Kontich, Belgium) and
NRecon (Ver. 1.6.9.4) software.
The use of ovariectomized white rats as a female osteoporosis 
model, included specific procedural guidelines and disease 
development findings, has been reported15). However, similar 
reports on male osteoporosis animal models are scarce, except 
for articles dealing with male osteoporosis risk factors16,19) and 
histological analyses7) in orchiectomized white rats. We sought 
to evaluate these issues in detail, and to statistically verify 
changes in bone mineral density (BMD) in our research.
In this study, we focused on the verification of BMD changes 
over time in rats bilaterally orchiectomized via a scrotal appro- 
ach (OCX), and to describe the specific procedures used to 
create our male osteopenia animal model.
MATERIALS AND METHODS
1. Animals
Twenty 10-week-old male rats purchased from Orient Bio 
(Gyonggi, Korea) (Sprague-Dawley, weight 210-220 g) were 
acclimated in a comfortable environment (temperature 22±
4℃, humidity 65±5%, day-night cycle 6:00 AM-6:00 PM). 
The environment was specific pathogen free. Two rats were 
housed in each stainless steel wire cage. The experimental group 
was randomly selected. This study was approved by the Yonsei 
University Health System Institutional Animal Care and Use 
Committee.
2. Experimental Design
Four 10-week-old rats (control group) were sacrificed, their 
femora were removed, and BMD was measured in these femora. 
The living 16 rats were divided into two groups. The sham 
operation (SO) group (n=8), underwent a sham operation at 
10 weeks of age, and the OCX group(n=8) underwent bilateral 
OCX, intended to change bone mineral density, at 10 weeks 
of age. Eight weeks after the OCX or SO, four rats from each 
of the two groups were sacrificed, and their femora were 
obtained and BMD was measured. Ten weeks after OCX or 
SO, the living rats in each group were sacrificed and the BMDs 
of their femora were measured. All rats were sacrificed using 
CO2 inhalation.
3. Femur BMD Measurement
Rats were euthanized at weeks 10, 18, and 20, and both 
femora from each rat were obtained. BMD was measured in 
the femora using micro computed tomography (CT): SkyScan 
1173 (Bruker-CT, Kartuizersweg 3B 2550 Kontich, Belgium) 
and NRecon (Ver. 1.6.9.4) software (Fig. 1).
4. Orchiectomy and Sham Operation Procedure
Anesthesia was induced with 5% isoflurane and Rompun 
(2.5 mg/kg, Bayer Korea) and Zoletil (5 mg/kg, Virbac Korea) 
were injected intra-peritoneally for generalized anesthesia. 2.5 
% isoflurane and oxygen were administered via a coaxial nose 
cone for anesthesia maintenance. Bilateral orchiectomy was 
performed via a scrotal approach. The anesthetized rat was 
placed supine on the operating table and its position was fixed 
using sticking tape. The scrotal hair was bilaterally shaved (Fig. 
2A). A betadine prep was performed as an aseptic maneuver 
(Fig. 2B). If the cremaster muscle was stimulated during the 
betadine prep, resulting in ascension of the testes, a downward 
stroke was performed to lower the testes back into place. A 
small, 1.0-cm median incision was made through the skin at 
the tip of the scrotum(Fig. 2C). The cremaster muscles were 
opened with a small, 7-mm incision. At the entrance to the 
scrotal cavity, the testicular fat pad was located and pulled 
through the incision using blunt forceps. The cauda epididymis 
was pulled out along with the testis, followed by the caput 
epididymis, the vas deferens and the testicular blood vessels 
(Fig. 2D). After identifying the testis, epididymis, vas deferens 
and testicular blood vessels, a single ligature was placed on the 
spermatic cord around the vas deferens and the blood vessels
(Fig. 2E). The testis and epididymis were removed. This pro- 
cedure was repeated for on the other testis and epididymis. 
The cremaster muscle and scrotal skin were sutured layer by 
Bone Mineral Density Changes after Orchiectomized Rats
Korean J Spine 12(2) June 2015 57
Fig. 2. Procedures for orchiectomy in rat. Anesthetized rat was
laid supine on the operating table. Scrotal shaving was done (A).
Betadine prep was performed as an aseptic maneuver (B). A small,
1.0-cm median incision was made through the skin at the tip of
the scrotum (C). The cremaster muscles were opened with a small
7-mm incision. Thick black arrow: cremaster muscle. The testi- 
cular fat pad was localized and pulled through the incision using
blunt forceps. The cauda epididymis was pulled out along with
the testis, followed by the caput epididymis, the vas deferens and
the testicular blood vessels (D). A single ligature was placed aro-
und the vas deferens and blood vessels (E). The testis was then
removed. This procedure was repeated for the other testis. Muscle 
and skin were sutured layer by layer (F). Thick white arrow: Testis
and epididymis surrounded by fat pad were totally removed.
Fig. 3. Micro CT Axial images of femora. (A, C) shows Sham 
group rats, each rats are POD 8 weeks and POD 10 weeks. (B, D)
shows OCX group rats, each rats are 8 weeks and 10 weeks.
layer (Fig. 2F).
The same preparation was performed on animals in the sham 
operation group, allowing the authors to visually identify the 
testis, epididymis, vas deferens and testicular blood vessels. After 
visual identification, the cremaster muscle and skin were sutu- 
red without ligation or resection.
5. Statistical Analysis
Statistical analysis was performed using SPSS software (ver- 
sion 20.0, Chicago, IL, USA). The Mann-Whitney test was used 
to compare values between the SO group and the OCX group, 
and the Wilcoxon signed-rank test was used to compare the 
mean values of BMD within the same group. Probability values 
<0.05 were considered statistical significant.
RESULTS
No procedural deaths occurred during the course of the ex- 
periment. Micro CT scan revealed male osteoporosis in orchie- 
ctomy group at POD 8 weeks and POD 10 weeks. There are 
marked deficiencies in trabecular bone (Fig. 3). Baseline BMD 
was measured in 10-week-old rats (control group) and a value 
of 0.244±0.073 g/cm3 was obtained. The mean femur BMD 
was significantly different between the OCX rats and the sham 
operation rats eight weeks after OCX (0.363±0.048 g/cm3 vs. 
0.205±0.019 g/cm3, p=0.029). The mean femur BMD was also 
significantly different between the OCX rats and the sham ope- 
ration rats ten weeks after OCX (0.451±0.076 g/cm3 vs. 0.280 
±0.008 g/cm3, p=0.029) (Table 1 and Fig. 4). No significant 
differences in chronologic BMD were found in the same groups, 
in accordance with Wilcoxon signedranked test.
DISCUSSION
The incidence of osteoporosis is rising in concordance with 
the rise in the geriatric population. Hence, understanding the 
etiology of osteoporosis will become helpful in improving the 
prognosis of spinal fusion surgery in osteoporotic patients. The 
morbidity and mortality of fracture in male osteoporosis patients 
are higher than those in the female population10), which nece- 
ssitates additional research on osteoporosis in men. In the cur- 
rent study, we analyzed changes in BMD in a representative 
animal model (bilateral OCX rat). Having an osteoporosis ani- 
mal model in which to analyze bone quality is essential for 
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Sham (8 weeks) 0.363 (±1.048) 0.029*
OCX (8 weeks) 0.205 (±0.019)
Sham (10 weeks) 0.451 (±0.176) 0.029*
OCX (10 weeks) 0.280 (±0.008) 　
POD, post operation date; Sham, sham surgery group; OCX, 
orchiectomy group.
Fig. 4. The changes in BMD(g/cm3) in the Sham and OCX groups.
The measured BMD was lowest at 8 weeks, after which BMD
increased.
research evaluating the effects and safety of treatments. OCX 
is classified as a gonadectomy which, along with ovariectomy, 
is a method for establishing an osteoporotic animal model12). 
This method is thought to be highly relevant to and represen- 
tative of prostate cancer patients with osteoporosis undergoing 
therapeutic androgen deprivation. There have been many arti- 
cles that have used ovariectomized rats as models for osteopo- 
rosis in postmenopausal women13). However, studies that detail 
the creation of precise male osteoporosis animal models and 
provide accompanying data on chronologic BMD results in 
these models have been lacking. Therefore, we sought to out- 
line the procedures we used and report the resulting changes 
in BMD we observed in the current study.
Orchiectomy can be performed by a few different methods. 
Surgical methods differ in the direction of approach and loca- 
tion of incisions. The usual approaches are on the scrotal and 
abdominal sides, and the skin incisions usually made are single 
midline scrotal, double median scrotal and midline abdominal 
incisions. We performed orchiectomy in rats using double me- 
dian scrotal incisions. We chose this method because the dou- 
ble median scrotal incision requires the shortest incision relative 
to the other possible single midline incisions. We also chose to 
use a scrotal approach because it allows for faster location of 
the testis, compared to an abdominal approach; thereby shor- 
tening the duration of operation. This study reports the seq- 
uential delineation of orchiectomy using double median scrotal 
incisions.
Previous studies have not been clear regarding the appropri- 
ate age of rats for the model or on the timing of significant BMD 
decreases after OCX when using the OCX rat model. In cases 
of ovariectomy, growing female rats tend to show a more sen- 
sitive skeletal response compared to aged female rats18). If skele- 
tally immature rats are used, a low peak bone mass is achieved. 
This is considered to be a high risk factor for human osteo- 
porotic problems. This trait is why the skeletally immature rat 
is an appropriate animal model for research on endocrine, 
nutritional and environmental factors, all of which can influ- 
ence peak bone mass12). We believed that growing orchiecto- 
mized rats would also show a greater response in their skeletal 
systems. Although rats reach sexual maturity at the age of 10 
weeks, their skeleton is considered mature after 10 months8). 
Because there is a time difference between endocrinologic matu- 
ration and skeletal system maturation, low peak bone mass was 
obtained by using 10-week-old orchiectomized rats.
There are a few reports of decreasing bone mass starting 
4 weeks after ovariectomy, which led to considerable bone mass 
loss at 8 and 10 weeks2,9). Although there are studies which 
found decreasing bone mass after orchiectomy and reports of 
osteoporosis following androgen deprivation in patients with 
prostate cancer, studies regarding the exact timing of this de- 
cline were lacking. This study revealed the exact timing of de- 
creasing bone quality with serial measurement using micro 
computed tomography. Both the 8-week and 10-week post- 
orchiectomy groups showed statistically significant reductions 
in bone mass in our study. However, BMD in the 8-week group 
was determined to be lower. Hence if one were to conduct 
a study using an animal model of male osteoporosis to evaluate 
many bone related variables and BMD measurements, our 8- 
week post-orchiectomy animal model would be most suited 
to this purpose.
Bone mass was shown to rise between weeks 8 and 10 after 
orchiectomy. In our study, as only 4 rats were used, the mean 
BMD we measured may not have been a precise representative 
of the entire rat species BMD. We believe that the increase 
in BMD observed after orchiectomy may have been due to other 
compensatory actions for the lack of sex hormones. Further- 
more, because a histologic evaluation of osteoid numbers after 
OCX was not conducted in the current study, further research 
pursuing chemical markers and using a pathological evaluation 
may be required.
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CONCLUSION
Osteoporotic animal models can be easily established using 
bilateral orchiectomy, the details of which we have described 
above. Statistically significant decreases in bone mass were obser- 
ved starting at 8 weeks post-operation. Bone mass increased 
over time even after bilateral orchiectomy, but was still statisti- 
cally significant compared to the sham operation group when 
measured at the same time.
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